Inhibitory effect of p27KIP1 gene transfer on head and neck squamous cell carcinoma cell lines

被引:15
作者
Koh, TY
Park, SW
Park, KH
Lee, SG
Seol, JG
Lee, DW
Lee, CT
Heo, DS
Kim, KH
Sung, MW
机构
[1] Seoul Natl Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Chongno Gu, Seoul 110744, South Korea
[2] Chungbuk Natl Univ, Coll Med, Dept Internal Med, Chongno Gu, Cheonju, South Korea
[3] Chungbuk Natl Univ, Coll Med, Inst Canc Res, Chongno Gu, Cheonju, South Korea
[4] Chungbuk Natl Univ, Coll Med, Clin Res Inst, Chongno Gu, Cheonju, South Korea
[5] Chungbuk Natl Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Chongno Gu, Cheonju, South Korea
[6] Chungbuk Natl Univ, Coll Med, Inst Med Res, Chongno Gu, Cheonju, South Korea
来源
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK | 2003年 / 25卷 / 01期
关键词
gene therapy; p27(KIP1); adenoviral vector; cell cycle; head and neck squamous cell carcinoma;
D O I
10.1002/hed.10166
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background. Although p27 gene mutations are rarely found in cancer, the level of p27 protein expression decreases during tumor development. In several tumors, including laryngeal cancer, decreased expression of p27 is associated with a poor prognosis. Methods. The proliferation-inhibitory effect of p27 gene transfer on human head and neck squamous cell carcinoma (HNSCC) cell lines (SNU-1041, SNU-1066, and SNU-1076) by adenoviral vector was investigated. Results. On transduction of the human HNSCC cell line with adenovirus-p27 (Ad-p27), a high level of p27 expression and increase of cyclin D1 and E were observed. Cell cycle analysis showed a marked decrease in the proportion of cells in S phase and an increase in G1 phase. Soft agar clonogenic assay showed a marked decrease in clonogenicity. Conclusion. These results suggested that overexpression of p27 could show proliferation-inhibitory effects on HNSCC cell lines. Thus, gene therapy using adenovirus-p27 seemed to have a potential to develop into a new cancer gene therapy modality. (C) 2002 Wiley Periodicals, Inc.
引用
收藏
页码:44 / 49
页数:6
相关论文
共 30 条
[1]   Decreased levels of the cell-cycle inhibitor p27(Kip1) protein: Prognostic implications in primary breast cancer [J].
Catzavelos, C ;
Bhatacharya, N ;
Ung, YC ;
Wilson, JA ;
Roncari, L ;
Sandhu, C ;
Shaw, P ;
Yeger, H ;
MoravaProtzner, I ;
Kapusta, L ;
Franssen, E ;
Pritchard, KI ;
Slingerland, JM .
NATURE MEDICINE, 1997, 3 (02) :227-230
[2]  
Catzavelos C, 1999, CANCER RES, V59, P684
[3]   New insights into the tumor suppression function of P27Kip1 [J].
Clurman, BE ;
Porter, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (26) :15158-15160
[4]   A recombinant adenovirus expressing p27(Kip1) induces cell cycle arrest and lass of cyclin-Cdk activity in human breast cancer cells [J].
Craig, C ;
Wersto, R ;
Kim, M ;
Ohri, E ;
Li, ZW ;
Katayose, D ;
Lee, SJ ;
Trepel, J ;
Cowan, K ;
Seth, P .
ONCOGENE, 1997, 14 (19) :2283-2289
[5]  
Esposito V, 1997, CANCER RES, V57, P3381
[6]   The murine gene p27Kip1 is haplo-insufficient for tumour suppression [J].
Fero, ML ;
Randel, E ;
Gurley, KE ;
Roberts, JM ;
Kemp, CJ .
NATURE, 1998, 396 (6707) :177-180
[7]  
Fiorentino M, 2000, CLIN CANCER RES, V6, P3966
[8]   Increased AKT activity contributes to prostate cancer progression by dramatically accelerating prostate tumor growth and diminishing p27Kip1 expression [J].
Graff, JR ;
Konicek, BW ;
McNulty, AM ;
Wang, ZJ ;
Houck, K ;
Allen, S ;
Paul, JD ;
Hbaiu, A ;
Goode, RG ;
Sandusky, GE ;
Vessella, RL ;
Neubauer, BL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (32) :24500-24505
[9]  
Hall M, 1996, ADV CANCER RES, V68, P67, DOI 10.1016/S0065-230X(08)60352-8
[10]   Concordant upregulation of type II-TGF-β-receptor, the cyclin-dependent kinases inhibitor P27Kip1 and cyclin E in human atherosclerotic tissue:: implications for lesion cellularity [J].
Ihling, C ;
Technau, K ;
Gross, V ;
Schulte-Mönting, J ;
Zeiher, AM ;
Schaefer, HE .
ATHEROSCLEROSIS, 1999, 144 (01) :7-14